Total and cause-specific mortality rates in a prospective study of community-acquired hepatitis C virus infection in northern Norway

Journal of Viral Hepatitis

Volumn 18, Issue 4, 2011, Pages 237-244

  Kristiansen, Magnhild Gangsøy ^a,b   Lochen M L ^b,c   Gutteberg, T J ^b,c   Mortensen, L ^a   Eriksen, B O ^b,c   Florholmen, J ^b,c  

^a NORDLAND HOSPITAL   (Norway)

^b UNIVERSITY OF TROMSØ   (Norway)

^c UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

Author keywords

Death rate; Hepatitis C; Mortality; Norway; Survival

Indexed keywords

ADULT; ALCOHOLISM; ARTICLE; CARDIOVASCULAR DISEASE; DRUG DEPENDENCE; DRUG USE; FEMALE; FOLLOW UP; HEPATITIS B; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOBLOTTING; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; MORTALITY; NEOPLASM; NORWAY; PRIORITY JOURNAL; SEX DIFFERENCE; SUICIDE; SURVIVAL RATE; VIRUS TRANSMISSION;

ADULT; COHORT STUDIES; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; FOLLOW-UP STUDIES; HEPATITIS C, CHRONIC; HUMANS; MALE; MIDDLE AGED; NORWAY; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 79952636786     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2010.01290.x     Document Type: Article

References (29)

1. Rantala M, van de Laar MJ. Surveillance and epidemiology of hepatitis B and C in Europe - a review. Euro Surveill 2008; 13: 1-8.
2. Sy T, Jamal MM. Epidemiology of hepatitis C virus (HCV) infection. Int J Med Sci 2006; 3: 41-46.
3. Poynard T, Yuen MF, Ratziu V, Lai CL. Viral hepatitis C. Lancet 2003; 362: 2095-2100. (Pubitemid 38035201)
4. Cole A. Hepatitis C morbidity is set to double in next decade. BMJ 2007; 334: 10.
5. Wong JB, McQuillan GM, McHutchison JG, Poynard T. Estimating future hepatitis C morbidity, mortality, and costs in the United States. Am J Public Health 2000; 90: 1562-1569.
6. Shepard CW, Finelli L, Alter MJ. Global epidemiology of hepatitis C virus infection. Lancet Infect Dis 2005; 5: 558-567. (Pubitemid 41196755)
7. Sweeting MJ, De AD, Brant LJ, Harris HE, Mann AG, Ramsay ME. The burden of hepatitis C in England. J Viral Hepat 2007; 14: 570-576. (Pubitemid 47075434)
8. Di Bisceglie AM, Goodman ZD, Ishak KG, Hoofnagle JH, Melpolder JJ, Alter HJ. Long-term clinical and histopathological follow-up of chronic posttransfusion hepatitis. Hepatology 1991; 14: 969-974.
9. Tremolada F, Casarin C, Alberti A et al. Long-term follow-up of non-A, non-B (type C) post-transfusion hepatitis. J Hepatol 1992; 16: 273-281. (Pubitemid 23013218)
10. Tong MJ, el-Farra NS, Reikes AR, Co RL. Clinical outcomes after transfusion-associated hepatitis C. N Engl J Med 1995; 332: 1463-1466.
11. Kenny-Walsh E. Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group. N Engl J Med 1999; 340: 1228-1233. (Pubitemid 29181642)
12. Rodger AJ, Roberts S, Lanigan A, Bowden S, Brown T, Crofts N. Assessment of long-term outcomes of community-acquired hepatitis C infection in a cohort with sera stored from 1971 to 1975. Hepatology 2000; 32: 582-587.
13. Wiese M, Grungreiff K, Guthoff W, Lafrenz M, Oesen U, Porst H. Outcome in a hepatitis C (genotype 1b) single source outbreak in Germany - a 25-year multicenter study. J Hepatol 2005; 43: 590-598. (Pubitemid 41253225)
14. Marc G, Ghany LBS. Efforts to define the natural history of chronic hepatitis C continue. Clin Gastroenterol Hepatol 2006; 4: 1190-1192.
15. Neal KR, Ramsay S, Thomson BJ, Irving WL. Excess mortality rates in a cohort of patients infected with the hepatitis C virus: a prospective study. Gut 2007; 56: 1098-1104. (Pubitemid 47123240)
16. Amin J, Law MG, Bartlett M, Kaldor JM, Dore GJ. Causes of death after diagnosis of hepatitis B or hepatitis C infection: a large community-based linkage study. Lancet 2006; 368: 938-945. (Pubitemid 44331386)
17. Duberg AS, Torner A, Davidsdottir L et al. Cause of death in individuals with chronic HBV and/or HCV infection, a nationwide community-based register study. J Viral Hepat 2008; 15: 538-550. (Pubitemid 351798992)
18. Kristiansen MG, Gutteberg T, Berg LK, Sjursen H, Mortensen L, Florholmen J. Hepatitis C in northern Norway. Tidsskr Nor Laegeforen 2002; 122: 1974-1976.
19. Kleinbaum DG, Klein M, (eds). Statistics for biology and health, survival analysis. 2nd edn. Springer, New York, 2005: 45-82.
20. Prasad L, Spicher VM, Negro F, Rickenbach M, Zwahlen M. Little evidence that hepatitis C virus leads to a higher risk of mortality in the absence of cirrhosis and excess alcohol intake: the Swiss Hepatitis C Cohort Study. J Viral Hepat 2009; 16: 644-649.
21. Wise M, Bialek S, Finelli L, Bell BP, Sorvillo F. Changing trends in hepatitis C-related mortality in the United States, 1995-2004. Hepatology 2008; 47: 1128-1135.
22. Jonsson AK, Holmgren P, Druid H, Ahlner J. Cause of death and drug use pattern in deceased drug addicts in Sweden, 2002-2003. Forensic Sci Int 2007; 169: 101-107. (Pubitemid 46829698)
23. Rai R, Wilson LE, Astemborski J et al. Severity and correlates of liver disease in hepatitis C virus-infected injection drug users. Hepatology 2002; 35: 1247-1255. (Pubitemid 34454022)
24. Miller CL, Kerr T, Strathdee SA, Li K, Wood E. Factors associated with premature mortality among young injection drug users in Vancouver. Harm Reduct J 2007; 4: 1-7.
25. Forns X, Ampurdanes S, Sanchez-Tapias JM et al. Long-term follow-up of chronic hepatitis C patients diagnosed at a tertiary-care center. J Hepatol 2001; 35: 265-271. (Pubitemid 32803483)
26. Massard J, Ratziu V, Thabut D et al. Natural history and predictors of disease severity in chronic hepatitis C. J Hepatol 2006; 1(Suppl): S19-S24. (Pubitemid 43053868)
27. Manesis EK, Papatheodoridis GV, Touloumi G et al. Natural course of treated and untreated chronic HCV infection: results of the nationwide Hepnet.Greece cohort study. Aliment Pharmacol Ther 2009; 29: 1121-1130.
28. Perumalswami PV, Bini EJ. Epidemiology, natural history, and treatment of hepatitis B virus and hepatitis C virus coinfection. Minerva Gastroenterol Dietol 2006; 52: 145-155. (Pubitemid 43774324)
29. Deuffic-Burban S, Deltenre P, Louvet A et al. Impact of viral eradication on mortality related to hepatitis C: a modelling approach in France. J Hepatol 2008; 49: 175-183.